AKT1 and colorectal cancer: It was also found that butyrate could inhibit the motility of colorectal cancer cells via inactivation of the AKT/ERK signaling pathway by histone deacetylation (58), which is very close to our results that the AKT/ERK signaling pathway is also closely related to the production of inflammatory factors.